REPROS THERAPEUTICS INC's ticker is and the CUSIP is 76028H959. A total of 2 filers reported holding REPROS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,075,000 | +7.1% | 2,793 | +3.1% | 0.08% | +19.7% |
| Q2 2015 | $1,937,000 | +16.2% | 2,709 | +39.6% | 0.07% | +2.9% |
| Q1 2015 | $1,667,000 | -47.1% | 1,941 | -38.6% | 0.07% | -31.0% |
| Q4 2014 | $3,152,000 | -8.0% | 3,161 | -8.6% | 0.10% | -24.2% |
| Q3 2014 | $3,425,000 | -42.6% | 3,460 | +0.3% | 0.13% | -48.4% |
| Q2 2014 | $5,969,000 | -0.2% | 3,450 | +2.3% | 0.26% | -23.6% |
| Q1 2014 | $5,980,000 | +11.3% | 3,371 | +14.9% | 0.34% | -2.0% |
| Q4 2013 | $5,371,000 | -65.0% | 2,935 | -48.8% | 0.34% | -65.7% |
| Q3 2013 | $15,362,000 | +255.2% | 5,732 | +144.5% | 1.00% | +245.3% |
| Q2 2013 | $4,325,000 | – | 2,344 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,450 | $5,969,000 | 0.26% |
| Citadel Advisors | 26,000 | $450,000 | 0.00% |